Regulation of IL-8 gene expression in gliomas by microRNA miR-93

Enrica Fabbri1, Eleonora Brognara2, Giulia Montagner3

  • 1Department of Life Sciences and Biotechnology, Section of Biochemistry and Molecular Biology, University of Ferrara, Via Fossato di Mortara n.74, 44121, Ferrara, Italy. enrica.fabbri@unife.it.

BMC Cancer
|October 10, 2015
PubMed
Abstract

Insights

MicroRNA miR-93 plays a key role in glioma angiogenesis by regulating Interleukin-8 (IL-8) and Vascular Endothelial Growth Factor (VEGF) expression. This finding offers new therapeutic targets for glioma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gliomas exhibit neoangiogenesis, with strategies beyond targeting VEGF being explored.
  • Interleukin-8 (IL-8) shows tumorigenic and proangiogenic properties in gliomas.
  • Limited data exist on the post-transcriptional regulation of IL-8 in gliomas.

Purpose of the Study:

  • To investigate the role of microRNA (miR-93) in regulating IL-8 and other pro-inflammatory gene expression in gliomas.
  • To explore the post-transcriptional regulatory mechanisms of IL-8 and VEGF in glioma angiogenesis.

Main Methods:

  • Quantitative reverse transcription PCR (RT-qPCR) and Bio-Plex analysis were employed.
  • Experiments utilized clinical glioma samples and two glioma cell lines (U251 and T98G).
  • In vitro transfections with pre-miR-93 and antagomiR-93 were performed.

Main Results:

  • IL-8 and VEGF transcripts were highly expressed in gliomas compared to healthy brain tissue.
  • miR-93 expression was increased and inversely correlated with IL-8 and VEGF transcription.
  • miR-93 directly modulated VEGF and IL-8 gene expression and protein release in glioma cell lines, also affecting MCP-1 and PDGF.

Conclusions:

  • miR-93 plays a significant role in regulating gene expression involved in glioma angiogenesis.
  • These findings highlight miR-93 as a potential therapeutic target for glioma treatment.
  • Further research into miR-93's regulatory network in gliomas is warranted.